Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Site, Randomized, Double-Blind Trial Assessing The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition

NCT03693105 is registered in ClinicalTrials.gov with Magnus Medical as lead sponsor.

NCT NCT03693105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03693105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Site, Randomized, Double-Blind Trial Assessing The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition
Lead sponsor
Magnus Medical
Phase
Phase 2/3
Overall status
Terminated
Start date
June 30, 2024
Completion date
March 6, 2025
Enrollment
2 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder, major depressive episode, suicidal ideation